F. Luciano-mateo,

, Benoit Viollet

, Jiri Neuzil

, Jorge Joven

M. Sanchez-martinez,

J. A. Menendez,

. R-e-f-e-r-e-n-c-e-s,

N. Barzilai, J. P. Crandall, S. B. Kritchevsky, and M. A. Espeland, Metformin as a tool to target aging, Cell Metabolism, vol.23, pp.1060-1065, 2016.

B. A. Benayoun, E. A. Pollina, and A. Brunet, Epigenetic regulation of ageing: Linking environmental inputs to genomic stability, Nature Reviews Molecular Cell Biology, vol.16, pp.593-610, 2015.

L. N. Booth and A. Brunet, The aging epigenome, Molecular Cell, vol.62, pp.728-744, 2016.

S. Boukalova, J. Stursa, L. Werner, Z. Ezrova, J. Cerny et al., Mitochondrial targeting of metformin enhances its activity against pancreatic cancer, Molecular Cancer Therapeutics, vol.15, pp.2875-2886, 2016.

H. R. Bridges, A. J. Jones, M. N. Pollak, and J. Hirst, Effects of metformin and other biguanides on oxidative phosphorylation in mitochondria, The Biochemical Journal, vol.462, pp.475-487, 2014.

H. R. Bridges, V. A. Sirvi?-o, A. N. Agip, and J. Hirst, Molecular features of biguanides required for targeting of mitochondrial respiratory complex I and activation of AMP-kinase, BMC Biology, vol.14, p.65, 2016.

B. Chance and G. Hollunger, Inhibition of electron and energy transfer in mitochondria. II. The site and the mechanism of guanidine action, Journal of Biological Chemistry, vol.238, pp.432-438, 1963.

N. S. Chandel, D. Avizonis, C. R. Reczek, S. E. Weinberg, S. Menz et al., Are metformin doses used in murine cancer models clinically relevant?, Cell Metabolism, vol.23, pp.569-570, 2016.

S. Cufi, B. Corominas-faja, A. Vazquez-martin, C. Oliveras-ferraros, J. Dorca et al.,

J. A. Menendez, S. Arroyo, S. Verdura, R. A. Garc-ia, J. Stursa et al., Metformininduced preferential killing of breast cancer initiating CD44 + CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2 + human breast cancer xenografts, Oncotarget, vol.3, pp.395-398, 2012.

J. A. Menendez, Metformin regulates global DNA methylation via mitochondrial one-carbon metabolism, Oncogene, vol.37, issue.7, p.963, 2017.

U. Deligezer, F. Yaman, E. Darendeliler, Y. Dizdar, S. Holdenrieder et al., Post-treatment circulating plasma BMP6 mRNA and H3K27 methylation levels discriminate metastatic prostate cancer from localized disease, Clinica Chimica Acta, vol.411, pp.1452-1456, 2010.

R. J. Dowling, S. Lam, C. Bassi, S. Mouaaz, A. Aman et al.,

V. Stambolic, Metformin pharmacokinetics in mouse tumors: Implications for human therapy, Cell Metabolism, vol.23, pp.567-568, 2016.

A. L. Egesipe, S. Blondel, A. L. Cicero, A. L. Jaskowiak, C. Navarro et al., Metformin decreases progerin expression and alleviates pathological defects of Hutchinson-Gilford progeria syndrome cells, NPJ Aging and Mechanisms of Disease, vol.2, p.16026, 2016.

S. Genheden and U. Ryde, The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities, Expert Opinion on Drug Discovery, vol.10, pp.449-461, 2015.

U. Gezer, E. E. Y?-or?-uker, M. Keskin, C. B. Kulle, Y. Dharuman et al., Histone methylation marks on circulating nucleosomes as novel blood-based biomarker in colorectal cancer, International Journal of Molecular Sciences, vol.16, pp.29654-29662, 2015.

H. Glossmann and N. Reider, A marriage of two "Methusalem" drugs for the treatment of psoriasis?: Arguments for a pilot trial with metformin as add-on for methotrexate, Dermato-endocrinology, vol.5, pp.252-263, 2013.

T. Griss, E. E. Vincent, R. Egnatchik, J. Chen, E. H. Ma et al.,

R. G. Jones, Metformin antagonizes cancer cell proliferation by suppressing mitochondrial-dependent biosynthesis, PLoS Biology, vol.13, 2015.
URL : https://hal.archives-ouvertes.fr/inserm-02135382

S. Han and A. Brunet, Histone methylation makes its mark on longevity, Trends in Cell Biology, vol.22, pp.42-49, 2012.

S. Heublein, S. Kazi, M. H. Ogmundsd-ottir, E. V. Attwood, S. Kala et al., Proton-assisted amino-acid transporters are conserved regulators of proliferation and aminoacid-dependent mTORC1 activation, Oncogene, vol.29, pp.4068-4079, 2010.

K. Holm, D. Grabau, K. L?-ovgren, S. Aradottir, S. Gruvberger-saal et al., Global H3K27 methylation and EZH2 abundance in breast tumor subtypes, Molecular Oncology, vol.6, pp.494-506, 2012.

C. Jin, J. Li, C. D. Green, X. Yu, X. Tang et al.,

J. D. Han, Histone demethylase UTX-1 regulates C. elegans life span by targeting the insulin/IGF-1 signaling pathway, Cell Metabolism, vol.14, pp.161-172, 2011.

J. K?-onig, F. M?-uller, and M. F. Fromm, Transporters and drug-drug interactions: Important determinants of drug disposition and effects, Pharmacological Reviews, vol.65, pp.944-966, 2013.

L. Kruidenier, C. W. Chung, Z. Cheng, J. Liddle, K. Che et al.,

D. M. Wilson, A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response, Nature, vol.488, pp.404-408, 2012.

S. Kumar, H. Pamulapati, and K. Tikoo, Fatty acid induced metabolic memory involves alterations in renal histone H3K36me2 and H3K27me3, Molecular and Cellular Endocrinology, vol.422, pp.233-242, 2016.

T. D. Lockwood, The lysosome among targets of metformin: New anti-inflammatory uses for an old drug?, Expert Opinion on Therapeutic Targets, vol.14, pp.467-478, 2010.

L. Logie, J. Harthill, K. Patel, S. Bacon, D. L. Hamilton et al., Cellular responses to the metal-binding properties of metformin, Diabetes, vol.61, pp.1423-1433, 2012.

C. L-opez-ot-in, M. A. Blasco, L. Partridge, M. Serrano, and G. Kroemer, The hallmarks of aging, Cell, vol.153, pp.1194-1217, 2013.

C. L-opez-ot-in, L. Galluzzi, J. M. Freije, F. Madeo, and G. Kroemer, Metabolic control of longevity, Cell, vol.166, pp.802-821, 2016.

B. Martin-castillo, J. Dorca, A. Vazquez-martin, C. Oliveras-ferraros, E. Lopez-bonet et al.,

J. A. Menendez, Incorporating the antidiabetic drug metformin in HER2-positive breast cancer treated with neo-adjuvant chemotherapy and trastuzumab: An ongoing clinical-translational research experience at the Catalan Institute of Oncology, Annals of Oncology, vol.21, pp.187-189, 2010.

B. Martin-castillo, C. Oliveras-ferraros, A. Vazquez-martin, S. Cuf-i, J. M. Moreno et al.,

J. A. Menendez, Basal/ HER2 breast carcinomas: Integrating molecular taxonomy with cancer stem cell dynamics to predict primary resistance to trastuzumab (Herceptin), Cell Cycle, vol.12, pp.225-245, 2013.

T. J. Maures, E. L. Greer, A. G. Hauswirth, and A. Brunet, The H3K27 demethylase UTX-1 regulates C. elegans lifespan in a germline-independent, insulin-dependent manner, Aging Cell, vol.10, pp.980-990, 2011.

P. Mcanena, J. A. Brown, and M. J. Kerin, Circulating nucleosomes and nucleosome modifications as biomarkers in cancer, Cancers, vol.9, 2017.

B. S. Mccauley and W. Dang, Histone methylation and aging: Lesson learned from model systems, Biochimica et Biophysica Acta, vol.1839, pp.1454-1462, 2014.

R. P. Mccord, A. Nazario-toole, H. Zhang, P. S. Chines, Y. Zhan et al., Correlated alterations in genome organization, histone methylation, and DNA-lamin A/C interactions in Hutchinson-Gilford progeria syndrome, Genome Research, vol.23, pp.260-269, 2013.

R. M. Memmott, J. R. Mercado, C. R. Maier, S. Kawabata, S. D. Fox et al., Metformin prevents tobacco carcinogen-induced lung tumorigenesis, Cancer Prevention Research, vol.3, pp.1066-1076, 2010.

J. A. Menendez, B. Martin-castillo, and J. Joven, Metformin and cancer: Quo vadis et cui bono?, Oncotarget, vol.7, pp.54096-54101, 2016.

R. J. Mishur, M. Khan, E. Munk-acsy, L. Sharma, A. Bokov et al.,

S. L. Rea, Mitochondrial metabolites extend lifespan, Aging Cell, vol.15, pp.336-348, 2016.

J. C. Newman, S. Milman, S. K. Hashmi, S. N. Austad, J. L. Kirkland et al., Strategies and challenges in clinical trials targeting human aging, Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, vol.71, pp.1424-1434, 2016.

F. Nigsch and J. B. Mitchell, How to winnow actives from inactives: Introducing molecular orthogonal sparse bigrams (MOSBs) and multiclass Winnow, Journal of Chemical Information and Modeling, vol.48, pp.306-318, 2008.

C. Oliveras-ferraros, B. Corominas-faja, S. Cuf-i, A. Vazquez-martin, B. Martin-castillo et al., Epithelial-to-mesenchymal transition (EMT) confers primary resistance to trastuzumab (Herceptin), Cell Cycle, vol.11, pp.4020-4032, 2012.

S. Pal and J. K. Tyler, Epigenetics and aging. Science Advances, 2, e1600584, 2016.

S. Pernas, J. Dorca, I. Alvarez-l-opez, S. Mart-inez, C. Saura et al., Safety and efficacy of neoadjuvant metformin with trastuzumab and chemotherapy in women with HER2-positive early breast cancer: A randomized, open-label, multicenter, phase 2 trial, San Antonio Breast Cancer Symposium (SABCS, 2017.

T. X. San-antonio, I. Pernicova, and M. Korbonits, Metformin-mode of action and clinical implications for diabetes and cancer, Nature Reviews. Endocrinology, vol.10, pp.143-156, 2014.

J. Piñero, A. Bravo, N. Queralt-rosinach, A. Guti-errez-sacrist-an, J. Deu-pons et al., DisGeNET: A comprehensive platform integrating information on human disease-associated genes and variants, Nucleic Acids Research, vol.45, pp.833-839, 2017.

S. Reagan-shaw, M. Nihal, and N. Ahmad, Dose translation from animal to human studies revisited, FASEB Journal, vol.22, pp.659-661, 2008.

M. Riera-borrull, A. Garc-ia-heredia, . Fern, S. Arroyo, . Hern et al., Metformin potentiates the benefits of dietary restraint: A metabolomic study, International Journal of Molecular Sciences, vol.18, 2017.

H. Sakaki, M. Okada, K. Kuramoto, H. Takeda, H. Watarai et al., GSKJ4, a selective jumonji H3K27 demethylase inhibitor, effectively targets ovarian cancer stem cells, Anticancer Research, vol.35, pp.6607-6614, 2015.

P. Scaffidi and T. Misteli, Reversal of the cellular phenotype in the premature aging disease Hutchinson-Gilford progeria syndrome, Nature Medicine, vol.11, pp.440-445, 2005.

P. Sen, W. Dang, G. Donahue, J. Dai, J. Dorsey et al.,

S. L. Berger, H3K36 methylation promotes longevity by enhancing transcriptional fidelity, Genes & Development, vol.29, pp.1362-1376, 2015.

T. Sengoku and S. Yokoyama, Structural basis for histone H3 Lys 27 demethylation by UTX/KDM6A, Genes & Development, vol.25, pp.2266-2277, 2011.

P. P. Shah, G. Donahue, G. L. Otte, B. C. Capell, D. M. Nelson et al.,

S. L. Berger, Lamin B1 depletion in senescent cells triggers large-scale changes in gene expression and the chromatin landscape, 2013.

, Genes & Development, vol.27, pp.1787-1799

K. B. Shpargel, T. Sengoku, S. Yokoyama, and T. Magnuson, UTX and UTY demonstrate histone demethylase-independent function in mouse embryonic development, PLoS Genetics, vol.8, 2012.

D. K. Shumaker, T. Dechat, A. Kohlmaier, S. A. Adam, M. R. Bozovsky et al., Mutant nuclear lamin A leads to progressive alterations of epigenetic control in premature aging, Proceedings of the National Academy of Sciences of the United States of America, vol.103, pp.8703-8708, 2006.

D. Sweeney, M. L. Raymer, and T. D. Lockwood, Antidiabetic and antimalarial biguanide drugs are metal-interactive antiproteolytic agents, Biochemical Pharmacology, vol.66, issue.03, pp.338-339, 2003.

A. S. Tan, J. W. Baty, L. F. Dong, A. Bezawork-geleta, B. Endaya et al., Mitochondrial genome acquisition restores respiratory function and tumorigenic potential of cancer cells without mitochondrial DNA, Cell Metabolism, vol.21, pp.81-94, 2015.

L. Tan, Z. Ke, G. Tombline, N. Macoretta, K. Hayes et al., Naked mole rat cells have a stable epigenome that resists iPSC reprogramming, Stem Cell Reports, vol.9, pp.1721-1734, 2017.

H. Tarhonskaya, R. P. Nowak, C. Johansson, A. Szykowska, A. Tumber et al.,

A. Kawamura, Studies on the interaction of the histone demethylase KDM5B with tricarboxylic acid cycle intermediates, Journal of Molecular Biology, vol.429, pp.2895-2906, 2017.

D. P. Thorne and T. D. Lockwood, Effect of Zn2 + on the proteolytic inhibitory action of insulin and biguanide antihyperglycemic drugs, Diabetes, vol.40, pp.612-620, 1991.

K. Tikoo, E. Sharma, V. R. Amara, H. Pamulapati, and V. S. Dhawale, Metformin improves metabolic memory in high fat diet (HFD)-induced renal dysfunction, Journal of Biological Chemistry, vol.291, pp.21848-21856, 2016.

A. Vazquez-martin, S. Cufi, E. Lopez-bonet, B. Corominas-faja, C. Oliveras-ferraros et al., Metformin limits the tumourigenicity of iPS cells without affecting their pluripotency, Scientific Reports, vol.2, p.964, 2012.

S. Vella, D. Gnani, A. Crudele, S. Ceccarelli, C. De-stefanis et al., EZH2 down-regulation exacerbates lipid accumulation and Inflammation in in vitro and in vivo NAFLD, International Journal of Molecular Sciences, vol.14, pp.24154-24168, 2013.

L. Wan, K. Xu, Y. Wei, J. Zhang, T. Han et al.,

W. Wei, Phosphorylation of EZH2 by AMPK suppresses PRC2 methyltransferase activity and oncogenic function, Molecular Cell, vol.69, pp.279-291, 2018.

H. Watarai, M. Okada, K. Kuramoto, H. Takeda, H. Sakaki et al., Loss of trimethylation at lysine 27 of histone H3 is a predictor of poor outcome in breast, ovarian, and pancreatic cancers, Molecular Carcinogenesis, vol.36, pp.701-706, 2008.

N. Yan, L. Xu, X. Wu, L. Zhang, X. Fei et al., , 2017.

, H3K27me3 demethylase inhibitor, effectively suppresses the breast cancer stem cells, GSKJ4, an, vol.359, pp.405-414

W. Zhang, J. Li, K. Suzuki, J. Qu, P. Wang et al.,

J. C. Belmonte, Aging stem cells. A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging, Science, vol.348, pp.1160-1163, 2015.

E. Verdura, S. Llorach-pares, and L. , Metformin directly targets the H3K27me3 demethylase KDM6A/UTX, Aging Cell, vol.17, p.12772, 2018.
URL : https://hal.archives-ouvertes.fr/inserm-02349904

,